MCC950, an NLRP3 inhibitor, or Ac-YVAD-CMK ameliorates neuronal pyroptosis and neuroinflammation in the hippocampus, thereby decreasing cognitive impairment [62]. This evidence concerns the gene NLRP3 and Cognitive impairment.